The newly developed cyanoacrylate adhesive device will be used to attach mesh with medical superglue in order to repair hernias.
Medical technology company AMS has received CE approval for a new device to be used in keyhole surgery.
The newly developed cyanoacrylate adhesive device will be used to attach mesh with medical superglue in order to repair hernias.
Previously, a surgeon would have used tacks or staples to attach the mesh. The new device can accurately and safely administer adhesive instead of tacks, giving the surgeon precision and control for the first time.
The application is expected to reduce surgical complications, in particular the potential pain associated with the use of tacks and staples, thereby improving the patient experience and reducing healthcare costs overall, said the firm.
The new device is part of AMS’ existing LiquiBand range of topical tissue adhesive products, which are designed for precise and controlled wound closure.
It will be marketed and distributed in the second half of this year by the group’s direct sales teams in the UK and Germany and through various distributor partners across the EU.
The Winsford, Cheshire-based firm is currently entering into a number of clinical evaluations.
Chris Meredith, chief executive said: “We are very pleased with this approval and the early interest in our new product. LiquiBand Fix 8 will benefit both patients and healthcare providers and is an important part of our strategy to increase our penetration of the operating theatre segment of the market.
“We believe that this innovation from our R&D pipeline will lead to further opportunities for this kind of application and to the development of a wider market for the use of adhesives internally.”
《AMS receives safety approval for new device》：
The newly developed cyanoacrylate adhesive device will be used to attach mesh with medical superglue in order to repair hernias.
Medical technology company AMS has received CE approval for a new device to be used in keyhole surgery.
The newly developed cyanoacrylate adhesive device will be used to attach mesh with medical superglue in order to repair hernias.
Previously, a surgeon would have used tacks or staples to attach the mesh. The new device can accurately and safely administer adhesive instead of tacks, giving the surgeon precision and control for the first time.
The application is expected to reduce surgical complications, in particular the potential pain associated with the use of tacks and staples, thereby improving the patient experience and reducing healthcare costs overall, said the firm.
The new device is part of AMS’ existing LiquiBand range of topical tissue adhesive products, which are designed for precise and controlled wound closure.
It will be marketed and distributed in the second half of this year by the group’s direct sales teams in the UK and Germany and through various distributor partners across the EU.
The Winsford, Cheshire-based firm is currently entering into a number of clinical evaluations.
Chris Meredith, chief executive said: “We are very pleased with this approval and the early interest in our new product. LiquiBand Fix 8 will benefit both patients and healthcare providers and is an important part of our strategy to increase our penetration of the operating theatre segment of the market.
“We believe that this innovation from our R&D pipeline will lead to further opportunities for this kind of application and to the development of a wider market for the use of adhesives internally.”